Neurodevelopmental Correlations between the Korean Developmental Screening Test and Bayley Scale III in Very-Low-Birth-Weight Infants

Han, Song; Kim, Og Hyang; Yoo, Chaeri; Heo, Ju Sun; Lee, Hyun-Seung; Jeon, Jihyun

doi:10.5385/nm.2020.27.4.167

Cited by 3 publications

(5 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, demographic and growth findings were comparable between patients with and without K-ASQ/K-DST (Supplementary Tables S2 and S3). Although K-ASQ and K-DST are tools based on parental reports, they showed good agreement with other tools including BSID-II and BSID-III [38,39]. Moreover, as infants get older, the results of questionnaire-based tools by parental reporting show better agreement with the results of examiner-led tests [40,41].…”

Section: Discussionmentioning

confidence: 91%

Head Growth and Neurodevelopment of Preterm Infants with Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation

Shin

Kim

et al. 2021

Children

View full text Add to dashboard Cite

Spontaneous intestinal perforation (SIP) and surgical necrotizing enterocolitis (NEC) are intestinal conditions requiring surgical intervention in preterm infants. We aimed to compare the head growth and neurodevelopment of preterm infants with SIP and surgical NEC. A retrospective single-center study was performed in preterm infants born at less than 32 weeks of gestation and who had undergone surgery for NEC or SIP. Data from the Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III) at 24 months of corrected age (CA) and the Korean Ages and Stages Questionnaire (K-ASQ) or Korean Developmental Screening Test (K-DST) at 36 months were collected. Among 82 eligible infants, 60 infants had surgical NEC, and 22 infants were diagnosed with SIP. Head growth was faster until CA 4 months in preterm infants with SIP than in those with surgical NEC. At 36 months, abnormal findings in the K-ASQ or K-DST were more prevalent in the NEC group than in the SIP group in the gross motor (48.2% vs. 0%, p = 0.015), fine motor (40.7% vs. 0%, p = 0.037), cognitive (55.6% vs. 12.5%, p = 0.047), and social domains (44.4% vs. 0%, p = 0.032). More studies evaluating the neurodevelopmental outcomes of preterm infants with surgical NEC and SIP are required.

show abstract

Section: Discussionmentioning

confidence: 91%

Head Growth and Neurodevelopment of Preterm Infants with Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation

Shin

Kim

et al. 2021

Children

View full text Add to dashboard Cite

show abstract

“…However, we expect our design of a randomized controlled trial would compensate for the lack of baseline data, since the BSID-III was validated as a tool for measuring development of infants and toddlers against their age-appropriate tasks [26]. Also, the Korean version of BSID-III test was validated in several researches and used in national cohort study in Korea to evaluate the neurodevelopment outcome in children [28][29][30][31][32]. Second, measurements of other biomarkers associated with neuroinflammation such as IL-1 or tumor necrosis factor-α are not included in our study.…”

Section: Discussionmentioning

confidence: 99%

“…Children with scores lower than 85, which is one standard deviation below the average, are recommended to undergo early intervention or therapy. We employed the Korean version of the BSID-III test which was validated in several researches and used in Korea for the detection of neurodevelopmental delays [28][29][30][31][32].…”

Section: Objectives {7}mentioning

confidence: 99%

The effect of dexmedetomidine on neuroprotection in pediatric cardiac surgery patients: study protocol for a prospective randomized controlled trial

Kang

Song

et al. 2022

Trials

View full text Add to dashboard Cite

Background Infants undergoing cardiac surgery under cardiopulmonary bypass are vulnerable to postoperative neurodevelopmental delays. Dexmedetomidine has been shown to have protective effects on the heart, kidneys, and brain in animals and adults undergoing cardiac surgery with cardiopulmonary bypass. We hypothesized that dexmedetomidine would have a neuroprotective effect on infants undergoing cardiopulmonary bypass and planned a prospective randomized controlled trial with postoperative neurodevelopment measurements. Methods This is a single-center, prospective, double-blinded, randomized controlled trial with 1:1 allocation. A cohort of 160 infants undergoing cardiac surgery with cardiopulmonary bypass will be enrolled. After induction, dexmedetomidine will be infused with a loading dose of 1 μg/kg and a maintenance dose of 0.5 μg/kg/h or the same amount of normal saline will be administered. Upon initiation of cardiopulmonary bypass, an additional dose of dexmedetomidine (0.01 μg/cardiopulmonary priming volume) will be mixed with the cardiopulmonary bypass circuit. The primary outcome will be the proportion of infants who score lower than 85 in any of the cognitive, language, or motor Bayley scales of infant development-III tests 1 year after the surgery. Other feasible outcome measures will include differences in plasma glial fibrillary acidic protein, troponin I, interleukin-6, urinary neutrophil gelatinase-associated lipocalin, and perioperative major adverse events. The results of the Bayley scales of infant development-III test from the study group and the control group will be compared using a chi-squared test under intention-to-treat analysis. A generalized estimating equation will be used to analyze repeated measurements over time. Discussion This study will enable us to assess whether the use of dexmedetomidine can alter the early neurodevelopmental outcome in infants undergoing cardiac surgery with cardiopulmonary bypass and also estimate effects of dexmedetomidine on other organs. Trial registration ClinicalTrials.gov NCT04484922. Registered on 24 July 2020

show abstract

“…27,28) Studies have demonstrated that the K-DST allows the accurate assessment of language and motor developmental delay 29) and has further neurodevelopmental implications among VLBW infants. 30) VLBW infants are also at higher risk for pathologies that may have neurodevelopmental implications. 31) The K-DST has facilitated the examination of pathologies such as retinopathy, 32,33) respiratory diseases, 34,35) brain injuries (cystic periventricular leukomalacia, 36) hypoxic-ischemic encephalopathy, 37) and thyroid dysfunction, 38) all of which can affect the neurodevelopment of VLBW infants.…”

Section: Very Low Birth Weight Infantsmentioning

confidence: 99%

“…The K-DST is effective for assessing the neurodevelopment of cognitive and language domains in VLBW infants [ 27 , 28 ]. Studies have demonstrated that the K-DST allows the accurate assessment of language and motor developmental delay [ 29 ] and has further neurodevelopmental implications among VLBW infants [ 30 ]. VLBW infants are also at higher risk for pathologies that may have neurodevelopmental implications [ 31 ].…”

Section: K-dst Efficacymentioning

confidence: 99%

Korean Developmental Screening Test for Infants and Children (K-DST): development, applications, and implications for future early childhood development interventions

Kim¹,

Choe²,

Durrani³

et al. 2023

Clin Exp Pediatr

View full text Add to dashboard Cite

Evidence of the importance of early childhood development (ECD) has transformed child health monitoring and screening tools. Development of the Korean Developmental Screening Test for Infants and Children (K-DST) has expanded the applications of child health screening to a large number of infants and children in Korea and is contributing to the early detection of neurodevelopmental disorders and delivery of timely interventions. The previous screening tool (Korean Ages and Stages Questionnaire) raised some concerns, as its lack of consideration of the cultural background of the Korean population can lead to inaccurate or imprecise diagnoses. The K-DST, a tailored tool for Korean infants and children, is a simple and costefficient solution for child health monitoring and screening. This review focuses on the development and role of the K-DST in ensuring ECD. Here we review use of the K-DST for ECD screenings and discuss the best strategy for its use in other countries.

show abstract

Neurodevelopmental Correlations between the Korean Developmental Screening Test and Bayley Scale III in Very-Low-Birth-Weight Infants

Cited by 3 publications

References 27 publications

Head Growth and Neurodevelopment of Preterm Infants with Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation

Head Growth and Neurodevelopment of Preterm Infants with Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation

The effect of dexmedetomidine on neuroprotection in pediatric cardiac surgery patients: study protocol for a prospective randomized controlled trial

Korean Developmental Screening Test for Infants and Children (K-DST): development, applications, and implications for future early childhood development interventions

Contact Info

Product

Resources

About